Archive for ◊ August, 2013 ◊

• Thursday, August 29th, 2013

Volcano Corporation Announces Execution Of Agreement To Purchase Pioneer Plus Re-Entry Catheter Product Line From Medtronic SAN DIEGO, Aug. 26, 2013 /PRNewswire/ — Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today it has signed an agreement […]

• Thursday, August 29th, 2013

Medinol, which wrung a $750 million patent infringement decision from Boston Scientific in 2005, sues Johnson & Johnson’s Cordis stent making arm. Cordis Corp., the stent-making arm of Johnson & Johnson (NYSE:JNJ), got out of the coronary stent game 2 years go, but that’s not stopping Israeli medical device company Medinol from suing Cordis for patent infringement […]

• Thursday, August 29th, 2013

InVivo Therapeutics Updates Clinical Plan CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced an update on the clinical timeline for its biopolymer scaffolding to treat acute SCI. The Company now expects that, based on the judgment of […]

• Wednesday, August 28th, 2013

Hansen Medical Closes Amended $33 Million Interest-Only Debt Facility Through 2017 MOUNTAIN VIEW, CA–(Marketwired – August 26, 2013) – Hansen Medical, Inc. (NASDAQ:HNSN), a global leader in intravascular robotics, announced that it closed a $33 million, long-term debt agreement with White Oak Global Advisors, LLC on August 23rd. The amended and restated senior secured loan […]

• Wednesday, August 28th, 2013

Response Genetics, Inc. Acquires Proprietary FDA-Cleared and Medicare-Reimbursed Test and All Associated Assets for Difficult to Diagnose Solid Tumors Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, today announced the acquisition of all of the key assets of Pathwork Diagnostics, including its FDA-cleared, Medicare-reimbursed test […]

• Wednesday, August 28th, 2013

Smith & Nephew and Northwest Ortho Plus come to a closed-doors agreement to settle all allegations in a $56 million trade secrets theft lawsuit. Healthcare giant Smith & Nephew (FTSE:SN, NYSE:SNN) came to terms with former staffing services provider Northwest Ortho Plus, putting to bed a year-old trade secrets dispute. The original lawsuit, which accused Northwest of damaging […]

• Wednesday, August 28th, 2013

Tissue Regeneration Systems Receives 510K Approval ANN ARBOR, Mich., Aug. 26, 2013 /PRNewswire/ — Tissue Regeneration Systems, Inc. (“TRS”) today announced that it has received 510K approval from the U.S. Food and Drug Administration for its Cranial Bone Void Filler product, indicated for use in the repair of neurosurgical burr holes. This is first of a family […]

• Tuesday, August 27th, 2013

San Antonio-based medical technology company AirStrip will work with Plano’s Vivify Health to develop a remote data-sharing platform to reduce hospital readmission rates for heart patients. The two companies’ platform will feature bi-directional data sharing via a near real-time, single point of access so medical professionals can improve clinical workflows and expedite care decisions about […]

• Tuesday, August 27th, 2013

A Texas judge permits Retractable Technologies Inc. to proceed with a lawsuit accusing rival Becton Dickinson of false advertising and violations of antitrust laws. Becton Dickinson & Co. (NYSE:BDX) is headed to court next month to speak to allegations, brought by rival Retractable Technologies’ (NYSE:RVP), that it engaged in illegal in order to maintain a monopoly in the syringe […]

• Tuesday, August 27th, 2013

Zimmer Receives FDA Clearance For Patient Specific Instruments (PSI) Shoulder WARSAW, Ind., Aug. 23, 2013 /PRNewswire/ — Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a world leader in musculoskeletal care, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Zimmer Patient Specific Instruments (PSI) Shoulder system to complement […]